The effects of Vitamin D on risk factors that leads to insulin resistance and glycemic status among Polycystic Ovary patients in a tertiary fertility hospital in Western part of Kenya.

Effects of Vitamin D on predictors of insulin resistance and glycemic status in Polycystic ovary syndrome at Mediheal Fertility Center in Eldoret; Western Kenya

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202401577278397

Enrollment

Registered

2024-01-12

Start date

2023-11-06

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertility-female

Interventions

Vitamin D plus Metformin

metformin

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Women between 18 and 50 years who will be diagnosed with polycystic ovary syndrome as per Rotterdam Criteria and consents to the study.

Exclusion criteria

Exclusion criteria: Pregnant women Patients taking vitamin D supplements other illnesses, such as liver disease, kidney disease, HIV, cancer or thyroid and parathyroid complications, diabetes mellitus, hypertension and heart failure

Design outcomes

Primary

Measure	Time frame
Effects of Vitamin D on hormonal profiles-,ANTIMULLERIAN,TESTOSTERONE,LH,LIPID PROFILES-total cholesterol,LDL,HDL and Tryglycerides,Cytokines-IL4,IL6,IL2,IL 10 and TNF Alpha,BMI,Waist-Hip ratio,HbA1C	—

Secondary

Measure	Time frame
Insulin resistance	—

Countries

Kenya

Contacts

Public ContactKARANI MAGUTAH

LECTURE AND RESEACHER

kmagutah@gmail.com+254721545063

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026